TrialCancer immunology, immunotherapy : CII2004

Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia.

Sophie Hallez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.